Resveratrol has been shown to inhibit vascular cell adhesion molecule (VCAM) expression in tissue culture. VCAM is expressed on the surface of the vascular endothelium (the innermost layer of cells in blood vessels) in response to oxidative stress. The expression of these proteins on the surface of endothelial cells provides an anchoring and entry point for inflammatory white blood cells.
These cells migrate across the endothelium into the middle layer of the artery, where they can become foam cells. Foam cells make up the bulk of arterial plaque. This suggests that resveratrol supplementation may prevent or slow the onset of atherosclerosis by preventing the invasion of the artery by immune cells.
These cells migrate across the endothelium into the middle layer of the artery, where they can become foam cells. Foam cells make up the bulk of arterial plaque. This suggests that resveratrol supplementation may prevent or slow the onset of atherosclerosis by preventing the invasion of the artery by immune cells.
Resveratrol inhibits vascular smooth muscle cell proliferation. Hypertension increases mechanical stress on arterial walls. The body responds to this by promoting the proliferation of vascular smooth muscle cells, which line the middle layer of the artery. This can cause the artery to thicken and become less distensible, leading to chronic hypertension and its consequences. Resveratrol has been shown to inhibit the proliferation of VSMCs in tissue cultures and in the body.
Resveratrol upregulates nitric oxide synthetase. The endothelium of the artery contains an enzyme that catalyzes the production of nitric oxide (NO). NO induces relaxation of the arterial tree. Dysregulation of NO homeostasis can contribute to increased blood pressure. In cultured endothelial cells, resveratrol has been shown to stimulate endothelial nitric oxide synthetase. This suggests that resveratrol may increase nitric oxide synthesis.
Resveratrol has been shown to inhibit platelet activation and aggregation. These processes are central to clot formation, which is potentially the most dangerous risk factor in cardiovascular disease.
Our quest is to differentiate ourselves from our competitors, by providing a distinct health care experience.